Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $88.3B |
| FY2017, ended Dec 31, 2017 | $102B |
| FY2018, ended Dec 31, 2018 | $91.8B |
| FY2019, ended Dec 31, 2019 | $130B |
| FY2020, ended Dec 31, 2020 | $109B |
| FY2021, ended Dec 31, 2021 | $128B |
| FY2022, ended Dec 31, 2022 | $148B |
| FY2023, ended Dec 31, 2023 | $112B |
| FY2024, ended Dec 31, 2024 | $154B |
| FY2025, ended Dec 31, 2025 | $246B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $251B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $57.2B |
| FY2017, ended Dec 31, 2017 | $59.8B |
| FY2018, ended Dec 31, 2018 | $34.7B |
| FY2019, ended Dec 31, 2019 | $45.3B |
| FY2020, ended Dec 31, 2020 | $56.6B |
| FY2021, ended Dec 31, 2021 | $64.4B |
| FY2022, ended Dec 31, 2022 | $67.1B |
| FY2023, ended Dec 31, 2023 | $68.9B |
| FY2024, ended Dec 31, 2024 | $80.7B |
| FY2025, ended Dec 31, 2025 | $88.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $96.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.05B | $4.71B |
| FY2017, ended Dec 31, 2017 | $4.55B | $3.62B |
| FY2018, ended Dec 31, 2018 | $5.27B | $1.20B |
| FY2019, ended Dec 31, 2019 | $5.54B | $3.95B |
| FY2020, ended Dec 31, 2020 | −$3.52B | $2.54B |
| FY2021, ended Dec 31, 2021 | $3.86B | $5.01B |
| FY2022, ended Dec 31, 2022 | $5.20B | $4.88B |
| FY2023, ended Dec 31, 2023 | $3.19B | $5.47B |
| FY2024, ended Dec 31, 2024 | $4.77B | $4.53B |
| FY2025, ended Dec 31, 2025 | $6.73B | $7.94B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $8.40B | $9.50B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.16B |
| FY2017, ended Dec 31, 2017 | $8.98B |
| FY2018, ended Dec 31, 2018 | $3.69B |
| FY2019, ended Dec 31, 2019 | $4.94B |
| FY2020, ended Dec 31, 2020 | $8.80B |
| FY2021, ended Dec 31, 2021 | $7.83B |
| FY2022, ended Dec 31, 2022 | $6.22B |
| FY2023, ended Dec 31, 2023 | $6.59B |
| FY2024, ended Dec 31, 2024 | $5.58B |
| FY2025, ended Dec 31, 2025 | $7.43B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $9.17B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $23.9B |
| FY2017, ended Dec 31, 2017 | $27.5B |
| FY2018, ended Dec 31, 2018 | $45.5B |
| FY2019, ended Dec 31, 2019 | $43.3B |
| FY2020, ended Dec 31, 2020 | $31.8B |
| FY2021, ended Dec 31, 2021 | $31.5B |
| FY2022, ended Dec 31, 2022 | $31.9B |
| FY2023, ended Dec 31, 2023 | $43.8B |
| FY2024, ended Dec 31, 2024 | $41.3B |
| FY2025, ended Dec 31, 2025 | $37.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $37.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 67.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 806M |
| FY2017, ended Dec 31, 2017 | 800M |
| FY2018, ended Dec 31, 2018 | 862M |
| FY2019, ended Dec 31, 2019 | 865M |
| FY2020, ended Dec 31, 2020 | 1.52B |
| FY2021, ended Dec 31, 2021 | 1.49B |
| FY2022, ended Dec 31, 2022 | 1.46B |
| FY2023, ended Dec 31, 2023 | 1.33B |
| FY2024, ended Dec 31, 2024 | 1.33B |
| FY2025, ended Dec 31, 2025 | 1.34B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 1.35B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.25B | $152M | $0 | — |
| FY2017, ended Dec 31, 2017 | $1.45B | $192M | $0 | — |
| FY2018, ended Dec 31, 2018 | $325M | $169M | — | $7.96B |
| FY2019, ended Dec 31, 2019 | $151M | $268M | — | — |
| FY2020, ended Dec 31, 2020 | $47.0M | $330M | — | — |
| FY2021, ended Dec 31, 2021 | $2.33B | $442M | — | — |
| FY2022, ended Dec 31, 2022 | $2.80B | $420M | — | — |
| FY2023, ended Dec 31, 2023 | $12.9B | $425M | — | — |
| FY2024, ended Dec 31, 2024 | $444M | $437M | — | — |
| FY2025, ended Dec 31, 2025 | $50.0M | $519M | — | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $0 | $637M | — | — |
Valuation
At current price- Market Cap
- $263B
- P/E
- 31.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.7×
- Price / Book
- 3.8×
- EV / EBITDA
- 18.6×
Growth
Trailing 12 months- Revenue (TTM)
- $96.0B
- Revenue Growth YoY
- 11.6%
- Revenue CAGR 3Y
- 9.7%
- Revenue CAGR 5Y
- 9.4%
- EPS Growth YoY
- 26.3%
- Net Income Growth YoY
- 27.5%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 11.8%
- Net Margin
- 8.8%
- FCF Margin
- 9.9%
- Return on Equity
- 12.6%
Earnings
Trailing 12 months- Net Income
- $8.40B
- EPS (diluted)
- $6.15
- EBITDA
- $15.7B
- Operating Income
- $11.3B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $9.17B
- Total Debt
- $37.4B
- Net Debt
- $28.2B
- Total Assets
- $177B
- Total Liabilities
- $106B
- Shareholders' Equity
- $69.3B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $12.4B
- Capital Expenditure
- $2.93B
- Free Cash Flow
- $9.50B
Dividends and risk
Last 12 months- Dividend Yield
- 1.4%
- Dividend / Share
- $2.82
- Beta (5Y)
- 0.31
Every ratio is calculated from the company’s reported figures.